USPTO trademark

ANDEMBRY

RegisteredUSPTOWord and designClass 5

"ANDEMBRY" is a word and design mark owned by CSL Behring GmbH, filed at the USPTO on January 21, 2026. It is registered and covers class 5 (Pharmaceuticals).

View CSL Behring GmbH portfolioGet this data via the API
Official USPTO record
ANDEMBRY trademark as filed
As filed with the USPTO
Status
Registered
Since June 9, 2026
Filed
January 21, 2026
Registered
June 9, 2026
Expires
Not recorded
Application no.
99605949
Registration no.
8295728
Office
USPTO
United States Patent and Trademark Office
Mark type
Word and design
1 class
Ownership

Who owns ANDEMBRY

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

CSL Behring GmbH

Marburg, Germany

305 trademarks in the portfolioView company

Representative

Scott Woldow

Smith, Gambrell & Russell, LLP

Goods and services

What the mark covers

The products and services ANDEMBRY is filed for, grouped by Nice class.

  • Pharmaceutical preparations for treating von Willebrand disease, hemophilia, primary immunodeficiency, hereditary angioedema, fibrinogen deficiency, Alpha 1 antitrypsin deficiency, and inflammatory demyelinating polyneuropathy; blood plasma; blood plasma fractions; recombinant protein arrays for medical diagnosis purposes; Pharmaceutical preparations for the treatment and prevention of blood and bleeding disorders; blood products for the treatment of hemophilia, namely, pharmaceutical preparations for the treatment of hemophilia; pharmaceutical products derived from recombinant DNA technology for the treatment of hemophilia, namely, pharmaceutical preparations derived from recombinant DNA technology for the treatment of hemophilia; blood products for the treatment of hemophilia, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations and substances for the treatment of blood disorders; antibodies, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; blood for medical purposes; cell cultures for medical purposes, namely, cells for medical or clinical use; cell cultures for medical purposes, namely, living cells for medical use; cell cultures for medical purposes, namely, stem cells for medical or veterinary use; pharmaceutical preparations for the treatment of blood conditions, respiratory conditions, pneumonia, covid-19, and influenza; Pharmaceutical preparations, namely, antibody for the treatment of acute respiratory distress syndrome, ARDS; pharmaceutical preparations, namely, antibody for the treatment of Idiopathic Pulmonary Fibrosis, IPF and Interstitial Lung Diseases, ILD; Pharmaceutical preparations, namely, antibody for the treatment of Hereditary Angioedema, HAE

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Registered-principal register
  2. Official gazette publication confirmation e-mailed
  3. Published for opposition
  4. Notification of notice of publication e-mailed
  5. Approved for pub - principal register
  6. Examiner's amendment entered
  7. Notification of examiners amendment e-mailed
  8. Examiners amendment e-mailed
  9. Examiners amendment -written
  10. Assigned to examiner

4 earlier steps on the official record.

FAQ

About ANDEMBRY

Who owns the trademark "ANDEMBRY"?

The USPTO trademark "ANDEMBRY" (application 99605949) is owned by CSL Behring GmbH.

What is the status of "ANDEMBRY"?

Its status at the USPTO is: registered.

When was "ANDEMBRY" registered?

It was registered on June 9, 2026.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ANDEMBRY and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2b90-01ef-713b-8c78-449f9fe39a55
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b90-01ef-713b-8c78-449f9fe39a55",
  "object": "trademark",
  "mark_text": "ANDEMBRY",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "99605949",
  "filing_date": "2026-01-21",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "CSL Behring GmbH",
      "entity_id": "ent_019eb6f7-2013-757e-9375-c0720a3cb498"
    }
  ]
}